Fri, 30th Apr 2021 19:06
RIO DE JANEIRO, April 30 (Reuters) - Brazilian
pharmaceutical sector associations on Friday called for the
rejection of a bill that seeks to suspend COVID-19 vaccine
patents, saying it could spark international retaliation and
reduce medical supplies in Latin America's biggest country.
Brazil's Senate passed the proposal, which the government
opposes, on Thursday night, sending it to the lower house for
consideration.
(Reporting by Gabriel Stargardter
Editing by Brad Haynes)
June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.
AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...
(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...
Astrazeneca (AZN)